XML 35 R28.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2013

Summary of changes in restricted share and option award outstanding

	Restricted shares				Options
	Shares		Wtd. Avg. Grant Price		Shares		Wtd. Avg. Ex. Price
December 31, 2010	92		$	33.74	314		$	22.39
Granted	20		36.69		32		36.69
Vested or Exercised	(35	)	26.81		(38	)	10.86
Forfeited	(6	)	34.76		(16	)	(28.05		)
December 31, 2011	71		$	37.85	292		$	25.15
Granted	29		24.16		63		24.16
Vested or Exercised	(44	)	37.61		(11	)	6.49
Forfeited	(6	)	28.55		(3	)	(20.19		)
December 31, 2012	50		$	31.35	341		$	25.62
Granted	58		20.29		68		20.71
Vested or Exercised	(8	)	19.57		(2	)	12.29
Forfeited	—		—		(24	)	(30.29		)
December 31, 2013	100		$	24.12	383		$	24.52

Summary of information about stock options

	Options Outstanding				Options Exercisable
Range of Exercise Price	Shares	Wtd. Avg. Remaining Contractual Life	Wtd. Avg. Exercise Price		Shares	Wtd. Avg. Remaining Contractual Life	Wtd. Avg. Exercise Price
$4.00-20.00	7	0.87	$	4.28	7	0.87	$	4.28
$20.01-30.00	279	5.75	$	21.01	170	3.79	$	20.50
Over $30.00	97	5.80	$	35.88	82	5.58	$	35.76
	383	5.68	$	24.52	259	4.28	$	24.89

Schedule of exercisable options and related information

	2013		2012		2011
Exercisable at end of year	259		240		219
Weighted average price	$	24.89	$	24.33	$	22.21

Weighted average fair value of options granted during the year	$	9.59	$	10.92	$	18.31

Schedule of unvested options

	Shares		Wtd. Avg. Ex. Price
December 31, 2012	101		$	28.69
Vested	34		31.02
Granted	68		20.71
Forfeited	(11	)	(28.40		)
December 31, 2013	124		$	23.77

Schedule of assumptions used in determining the fair value option awards

Grant date		Equivalent interest rate		Equivalent volatility		Implied expected lives
March 1, 2013		1.86	%	40.00	%	8.33

- Definition

Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.

+ References+ Details